Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus-Peter Heussel

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Frontiers in Oncology|December 18, 2020
Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer-Cross-Sectional Study of Eligibility and Administration RatesTanja Eichkorn, Farastuk Bozorgmehr, Sebastian Regnery, et al.
Pneumologie (Stuttgart, Germany)|March 28, 2023
[Consensus guideline on the interdisciplinary diagnosis of interstitial lung diseases]Michael Kreuter, Jürgen Behr, Francesco Bonella, et al.
Investigative Radiology|December 17, 2024
Metastasis Detection Using True and Artificial T1-Weighted Postcontrast Images in Brain MRIRobert Haase, Thomas Pinetz, Erich Kobler, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2016
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical OncologyMarie von Lilienfeld-Toal, Annemarie Berger, Maximilian Christopeit, et al.
Therapeutic Advances in Medical Oncology|August 19, 2021
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancerNikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2007
Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)Oliver A Cornely, Johan Maertens, Mark Bresnik, et al.
Haematologica|July 17, 2010
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI studyCatherine Cordonnier, Montserrat Rovira, Johan Maertens, et al.
Cancers|January 24, 2019
Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor SurvivalPetros Christopoulos, Steffen Dietz, Martina Kirchner, et al.
International Journal of Cancer|April 20, 2026
Neoadjuvant Atezolizumab and Chemotherapy for Non-Squamous Non-Small Cell Lung Cancer: Efficacy and Safety Results of an Open-Label, Single-Arm, Phase II TrialBenedikt Niedermaier, Tilmann Bochtler, Florian Eichhorn, et al.
Translational Lung Cancer Research|September 21, 2020
Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectivesSabine Wessels, Thomas Muley, Petros Christopoulos, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Frontiers in Oncology|December 18, 2020
Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer-Cross-Sectional Study of Eligibility and Administration RatesTanja Eichkorn, Farastuk Bozorgmehr, Sebastian Regnery, et al.
Pneumologie (Stuttgart, Germany)|March 28, 2023
[Consensus guideline on the interdisciplinary diagnosis of interstitial lung diseases]Michael Kreuter, Jürgen Behr, Francesco Bonella, et al.
Investigative Radiology|December 17, 2024
Metastasis Detection Using True and Artificial T1-Weighted Postcontrast Images in Brain MRIRobert Haase, Thomas Pinetz, Erich Kobler, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2016
Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical OncologyMarie von Lilienfeld-Toal, Annemarie Berger, Maximilian Christopeit, et al.
Therapeutic Advances in Medical Oncology|August 19, 2021
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancerNikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2007
Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)Oliver A Cornely, Johan Maertens, Mark Bresnik, et al.
Haematologica|July 17, 2010
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI studyCatherine Cordonnier, Montserrat Rovira, Johan Maertens, et al.
Cancers|January 24, 2019
Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor SurvivalPetros Christopoulos, Steffen Dietz, Martina Kirchner, et al.
International Journal of Cancer|April 20, 2026
Neoadjuvant Atezolizumab and Chemotherapy for Non-Squamous Non-Small Cell Lung Cancer: Efficacy and Safety Results of an Open-Label, Single-Arm, Phase II TrialBenedikt Niedermaier, Tilmann Bochtler, Florian Eichhorn, et al.
Translational Lung Cancer Research|September 21, 2020
Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectivesSabine Wessels, Thomas Muley, Petros Christopoulos, et al.
Pageof 14